Abstract
Pre-treatment with the anabolic steroid nandrolone decanoate (ND) increases the LD50 of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 5-Fluorouracil (FU) in NMRI mice. Administration of ND did not affect the anti-tumour action of CCNU against a transplantable mouse adenocarcinoma of the colon (MAC 13) or the anti-tumour action of FU against MAC 26. In both tumour lines ND had no significant effect on tumour growth. These data suggest that an increase in the anti-tumour selectivity of these agents may be produced by pre-treatment with ND.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Bibby, M., Double, J. & Mughal, M. Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours. Br J Cancer 44, 572–577 (1981). https://doi.org/10.1038/bjc.1981.228
Issue date:
DOI: https://doi.org/10.1038/bjc.1981.228
This article is cited by
-
Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression
Scientific Reports (2020)
-
Biotransformation of androst-4-ene-3,17-dione and nandrolone decanoate by genera of Aspergillus and Fusarium
Biotechnology Letters (2020)